Literature DB >> 32227231

A Fyn romance: tumor cell Fyn kinase suppresses the immune microenvironment.

Sachendra S Bais1,2, Milan G Chheda1,2,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32227231      PMCID： PMC7283015          DOI： 10.1093/neuonc/noaa082

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN： 1522-8517            Impact factor:   12.300


× No keyword cloud information.
  10 in total

1.  Neurofibromatosis-1 (Nf1) heterozygous brain microglia elaborate paracrine factors that promote Nf1-deficient astrocyte and glioma growth.

Authors:  Girish C Daginakatte; David H Gutmann
Journal:  Hum Mol Genet       Date:  2007-03-30       Impact factor: 6.150

2.  Cellular and Molecular Identity of Tumor-Associated Macrophages in Glioblastoma.

Authors:  Zhihong Chen; Xi Feng; Cameron J Herting; Virginia Alvarez Garcia; Kai Nie; Winnie W Pong; Rikke Rasmussen; Bhakti Dwivedi; Sandra Seby; Susanne A Wolf; David H Gutmann; Dolores Hambardzumyan
Journal:  Cancer Res       Date:  2017-02-24       Impact factor: 12.701

3.  Sex differences in GBM revealed by analysis of patient imaging, transcriptome, and survival data.

Authors:  Wei Yang; Nicole M Warrington; Sara J Taylor; Paula Whitmire; Eduardo Carrasco; Kyle W Singleton; Ningying Wu; Justin D Lathia; Michael E Berens; Albert H Kim; Jill S Barnholtz-Sloan; Kristin R Swanson; Jingqin Luo; Joshua B Rubin
Journal:  Sci Transl Med       Date:  2019-01-02       Impact factor: 17.956

4.  Glioblastoma-infiltrated innate immune cells resemble M0 macrophage phenotype.

Authors:  Konrad Gabrusiewicz; Benjamin Rodriguez; Jun Wei; Yuuri Hashimoto; Luke M Healy; Sourindra N Maiti; Ginu Thomas; Shouhao Zhou; Qianghu Wang; Ahmed Elakkad; Brandon D Liebelt; Nasser K Yaghi; Ravesanker Ezhilarasan; Neal Huang; Jeffrey S Weinberg; Sujit S Prabhu; Ganesh Rao; Raymond Sawaya; Lauren A Langford; Janet M Bruner; Gregory N Fuller; Amit Bar-Or; Wei Li; Rivka R Colen; Michael A Curran; Krishna P Bhat; Jack P Antel; Laurence J Cooper; Erik P Sulman; Amy B Heimberger
Journal:  JCI Insight       Date:  2016-02-25

5.  pp59fyn mutant mice display differential signaling in thymocytes and peripheral T cells.

Authors:  P L Stein; H M Lee; S Rich; P Soriano
Journal:  Cell       Date:  1992-09-04       Impact factor: 41.582

6.  Fyn and SRC are effectors of oncogenic epidermal growth factor receptor signaling in glioblastoma patients.

Authors:  Kan V Lu; Shaojun Zhu; Anna Cvrljevic; Tiffany T Huang; Shawn Sarkaria; David Ahkavan; Julie Dang; Eduard B Dinca; Seema B Plaisier; Isaac Oderberg; Yohan Lee; Zugen Chen; Jeremy S Caldwell; Yongmin Xie; Joseph A Loo; David Seligson; Arnab Chakravari; Francis Y Lee; Roberto Weinmann; Timothy F Cloughesy; Stanley F Nelson; Gabriele Bergers; Thomas Graeber; Frank B Furnari; C David James; Webster K Cavenee; Terrance G Johns; Paul S Mischel
Journal:  Cancer Res       Date:  2009-08-18       Impact factor: 12.701

7.  Cancer Stem Cell-Secreted Macrophage Migration Inhibitory Factor Stimulates Myeloid Derived Suppressor Cell Function and Facilitates Glioblastoma Immune Evasion.

Authors:  Balint Otvos; Daniel J Silver; Erin E Mulkearns-Hubert; Alvaro G Alvarado; Soumya M Turaga; Mia D Sorensen; Patricia Rayman; William A Flavahan; James S Hale; Kevin Stoltz; Maksim Sinyuk; Qiulian Wu; Awad Jarrar; Sung-Hak Kim; Paul L Fox; Ichiro Nakano; Jeremy N Rich; Richard M Ransohoff; James Finke; Bjarne W Kristensen; Michael A Vogelbaum; Justin D Lathia
Journal:  Stem Cells       Date:  2016-05-27       Impact factor: 6.277

8.  GM-CSF promotes the immunosuppressive activity of glioma-infiltrating myeloid cells through interleukin-4 receptor-α.

Authors:  Gary Kohanbash; Kayla McKaveney; Masashi Sakaki; Ryo Ueda; Arlan H Mintz; Nduka Amankulor; Mitsugu Fujita; John R Ohlfest; Hideho Okada
Journal:  Cancer Res       Date:  2013-09-12       Impact factor: 12.701

9.  Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma.

Authors:  Timothy F Cloughesy; Aaron Y Mochizuki; Joey R Orpilla; Willy Hugo; Alexander H Lee; Tom B Davidson; Anthony C Wang; Benjamin M Ellingson; Julie A Rytlewski; Catherine M Sanders; Eric S Kawaguchi; Lin Du; Gang Li; William H Yong; Sarah C Gaffey; Adam L Cohen; Ingo K Mellinghoff; Eudocia Q Lee; David A Reardon; Barbara J O'Brien; Nicholas A Butowski; Phioanh L Nghiemphu; Jennifer L Clarke; Isabel C Arrillaga-Romany; Howard Colman; Thomas J Kaley; John F de Groot; Linda M Liau; Patrick Y Wen; Robert M Prins
Journal:  Nat Med       Date:  2019-02-11       Impact factor: 53.440

10.  Fyn tyrosine kinase, a downstream target of receptor tyrosine kinases, modulates antiglioma immune responses.

Authors:  Andrea Comba; Patrick J Dunn; Anna E Argento; Padma Kadiyala; Maria Ventosa; Priti Patel; Daniel B Zamler; Felipe J Núñez; Lili Zhao; Maria G Castro; Pedro R Lowenstein
Journal:  Neuro Oncol       Date:  2020-06-09       Impact factor: 12.300
  10 in total
  1 in total

Review 1.  Genetic Alterations in Gliomas Remodel the Tumor Immune Microenvironment and Impact Immune-Mediated Therapies.

Authors:  Maria B Garcia-Fabiani; Santiago Haase; Andrea Comba; Stephen Carney; Brandon McClellan; Kaushik Banerjee; Mahmoud S Alghamri; Faisal Syed; Padma Kadiyala; Felipe J Nunez; Marianela Candolfi; Antonela Asad; Nazareno Gonzalez; Marisa E Aikins; Anna Schwendeman; James J Moon; Pedro R Lowenstein; Maria G Castro
Journal:  Front Oncol       Date:  2021-06-08       Impact factor: 5.738
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.